Jump to content
  • Sign Up
0
Scott Adams

Trial Data: ALV003 Reduces Gluten Damage in Celiac Disease Patients - Celiac.com

Rate this topic

Recommended Posts

Celiac.com

Trial Data: ALV003 Reduces Gluten Damage in Celiac Disease Patients

Celiac.com

Celiac.com 07/23/2012 - At 2012 Digestive Diseases Week in San Diego, California, Alvine Pharmaceuticals, Inc. announced the publication of data from Phase 2A trial of its main celiac disease compound, ALV003. Photo: CC--Carolina Biological Supply ...

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×